Purchase this article with an account.
Michael E. Stern, Karyn Siemasko, Jianping Gao, Anh Duong, Clay Beauregard, Virginia Calder, Jerry Y. Niederkorn; Role of Interferon-γ in a Mouse Model of Allergic Conjunctivitis. Invest. Ophthalmol. Vis. Sci. 2005;46(9):3239-3246. doi: https://doi.org/10.1167/iovs.05-0138.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
purpose. To characterize the effect of repeated topical exposure to allergen in a mouse model of allergic conjunctivitis and to determine the role of interferon-γ (IFN-γ) in the pathogenesis of allergic conjunctivitis.
methods. Wild-type BALB/c mice and IFN-γ knockout (KO) BALB/c mice were sensitized in the footpad with short ragweed (SRW) allergen and challenged topically for seven consecutive days with SRW allergen. The number of splenic CD4+ Th2 cells was determined by flow cytometry, and the cytokine profile of CD4+ T cells from SRW-sensitized mice was evaluated by ELISA. The role of IFN-γ in allergic conjunctivitis was also examined by timed in vivo neutralization with anti-IFN-γ antibody. Allergic conjunctivitis was evaluated clinically and histopathologically.
results. Repeated topical challenge with SRW allergen induced allergic conjunctivitis that was characterized by lid edema, chemosis, redness, and tearing. Histopathological analysis revealed a marked conjunctival infiltrate that was predominantly neutrophils and eosinophils. IFN-γ KO mice and normal mice treated with anti-IFN-γ antibody displayed milder clinical symptoms of allergic conjunctivitis and a 70% reduction in the number of eosinophils that infiltrated the conjunctiva. Spleen cells from SRW-sensitized mice contained a large population of cells that expressed the Th2 surface marker T1/ST2 and produced IL-4, -5, and -10 and IFN-γ after stimulation with SRW allergen.
conclusions. Repeated topical application of SRW allergen induces a form of murine allergic conjunctivitis that mimics the human counterpart. IFN-γ appears to contribute to the pathogenesis of murine allergic conjunctivitis at the effector phase, but not during the initial sensitization stage.
This PDF is available to Subscribers Only